{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:49:35Z","timestamp":1790718575777,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"University Grants Commission - Special Assistance Programme","award":["F3.16\/2015\/DRS2\/SAP2"],"award-info":[{"award-number":["F3.16\/2015\/DRS2\/SAP2"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.bone.2018.05.011","type":"journal-article","created":{"date-parts":[[2018,5,12]],"date-time":"2018-05-12T06:52:43Z","timestamp":1526107963000},"page":"57-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats"],"prefix":"10.1016","volume":"113","author":[{"given":"Bushra","family":"Parveen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambrish Kumar","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhashis","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naibedya","family":"Chattopadhyay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1852-9191","authenticated-orcid":false,"given":"Divya","family":"Vohora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2018.05.011_bb0005","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1517\/14740338.2014.919255","article-title":"The problem of osteoporosis in epileptic patients taking antiepileptic drugs","volume":"13","author":"Miziak","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.bone.2018.05.011_bb0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.pediatrneurol.2004.03.021","article-title":"Effect of carbamazepine and valproate on bone mineral density","volume":"31","author":"Ecevit","year":"2004","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.bone.2018.05.011_bb0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1515\/jpem-2006-190411","article-title":"Effect of carbamezapine and valproic acid on bone mineral density, IGF-I and IGFBP-3","volume":"19","author":"Kumandas","year":"2006","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"10.1016\/j.bone.2018.05.011_bb0020","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/187152711794653797","article-title":"Homocysteine in neurological disease: a marker or a cause?","volume":"10","author":"Khanna","year":"2011","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.bone.2018.05.011_bb0025","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.drudis.2009.01.004","article-title":"Insights into liaison between antiepileptic drugs and bone","volume":"14","author":"Khanna","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bone.2018.05.011_bb0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.eplepsyres.2013.08.012","article-title":"The effect of levetiracetam on rat bone mass, structure and metabolism","volume":"107","author":"Fekete","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0035","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s00223-016-0109-7","article-title":"Monotherapy with levetiracetam versus older AEDs: a randomized comparative trial of effects on bone health","volume":"98","author":"Hakami","year":"2016","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.bone.2018.05.011_bb0040","doi-asserted-by":"crossref","first-page":"460210","DOI":"10.1155\/2013\/460210","article-title":"Serum dickkopf-1 level in postmenopausal females: correlation with bone mineral density and serum biochemical markers","volume":"2013","author":"Ahmed","year":"2013","journal-title":"J. Osteoporos."},{"key":"10.1016\/j.bone.2018.05.011_bb0045","first-page":"263","article-title":"Osteoporosis in Indians","volume":"127","author":"Malhotra","year":"2008","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0050","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ajog.2005.08.047","article-title":"Epidemiology, etiology, and diagnosis of osteoporosis","volume":"194","author":"Lane","year":"2006","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"614","key":"10.1016\/j.bone.2018.05.011_bb0055","article-title":"Rodent models of osteoporosis","volume":"3","author":"Sophocleous","year":"2014","journal-title":"BoneKey Rep."},{"key":"10.1016\/j.bone.2018.05.011_bb0060","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejps.2014.05.018","article-title":"Raloxifene preserves phenytoin and sodium valproate induced bone loss by modulating serum estradiol and TGF-\u03b23 content in bone of female mice","volume":"62","author":"Anwar","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bone.2018.05.011_bb0065","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.seizure.2007.11.024","article-title":"How can antiepileptic drugs affect bone mass, structure and metabolism? Lessons from animal studies","volume":"17","author":"Nissen-Meyer","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.bone.2018.05.011_bb0070","doi-asserted-by":"crossref","first-page":"240","DOI":"10.17305\/bjbms.2012.2445","article-title":"Effects of carbamazepine on serum parathormone, 25- hydroxyvitamin D, bone specific alkaline phosphatase, C-telopeptide, and osteocalcin levels in healthy rats","volume":"12","author":"Kir","year":"2012","journal-title":"Bosn. J. Basic Med. Sci."},{"key":"10.1016\/j.bone.2018.05.011_bb0075","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1002\/jbmr.434","article-title":"A novel quercetin analogue from a medicinal plant promotes peak bone mass achievement and bone healing after injury and exerts an anabolic effect on osteoporotic bone: the role of aryl hydrocarbon receptor as a mediator of osteogenic action","volume":"26","author":"Sharan","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0080","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mce.2016.11.005","article-title":"Effects of raloxifene against letrozole-induced bone loss in chemically-induced model of menopause in mice","volume":"440","author":"Kalam","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.bone.2018.05.011_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00198-006-0185-z","article-title":"Anti-epileptic medication and bone health","volume":"18","author":"Petty","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.05.011_bb0090","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0031-9384(87)90235-6","article-title":"Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in rats","volume":"39","author":"McElroy","year":"1987","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.bone.2018.05.011_bb0095","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.3945\/jn.108.093781","article-title":"Ovariectomy-induced hyperphagia does not modulate bone mineral density or bone strength in rats","volume":"138","author":"Jiang","year":"2008","journal-title":"J. Nutr."},{"key":"10.1016\/j.bone.2018.05.011_bb0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1528-1167.2007.01273.x","article-title":"Dramatic weight loss with levetiracetam","volume":"49","author":"Gelisse","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.bone.2018.05.011_bb0105","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11920-007-0071-1","article-title":"Weight gain and metabolic issues of medicines used for bipolar disorder","volume":"9","author":"Fagiolini","year":"2007","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.bone.2018.05.011_bb0110","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jocd.2016.07.008","article-title":"Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy","volume":"19","author":"Ahmad","year":"2016","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2018.05.011_bb0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clineuro.2016.04.019","article-title":"Bone health and vitamin D status in young epilepsy patients on valproate monotherapy","volume":"146","author":"Albaghdadi","year":"2016","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.bone.2018.05.011_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.phrs.2003.11.011","article-title":"The effect of valproate on bone mineral density in adult epileptic patients","volume":"50","author":"Boluk","year":"2004","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0125","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.yebeh.2006.11.007","article-title":"A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy","volume":"10","author":"Kim","year":"2007","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.bone.2018.05.011_bb0130","series-title":"Bone Densitometry in Clinical Practice: Application and Interpretation","author":"Bonnick","year":"2009"},{"key":"10.1016\/j.bone.2018.05.011_bb0135","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1248\/bpb.b17-00482","article-title":"Effects of the antiepileptic drugs phenytoin, gabapentin, and levetiracetam on bone strength, bone mass, and bone turnover in rats","volume":"40","author":"Kanda","year":"2017","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bone.2018.05.011_bb0140","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.eplepsyres.2012.09.002","article-title":"Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy","volume":"104","author":"Koo","year":"2013","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3340\/jkns.2010.48.4.309","article-title":"Bone mineral density changes after ovariectomy in rats as an osteopenic model: stepwise description of double dorso-lateral approach","volume":"48","author":"Park","year":"2010","journal-title":"J. Korean Neurosurg. Soc."},{"key":"10.1016\/j.bone.2018.05.011_bb0150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/00365510802233442","article-title":"Reduced bone mass and increased bone turnover in postmenopausal women with epilepsy using antiepileptic drug monotherapy","volume":"68","author":"Lyngstad-Brechan","year":"2008","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1016\/j.bone.2018.05.011_bb0155","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1359\/jbmr.091027","article-title":"Antiepileptic drug use, falls, fractures, and BMD in postmenopausal women: findings from the women's health initiative (WHI)","volume":"25","author":"Carbone","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0404.2005.00474.x","article-title":"Epilepsy, osteoporosis and fracture risk - a meta-analysis","volume":"112","author":"Vestergaard","year":"2005","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bone.2018.05.011_bb0165","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jor.20063","article-title":"Bone loss dynamics result in trabecular alignment in aging and ovariectomized rats","volume":"24","author":"Waarsing","year":"2006","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0170","first-page":"316","article-title":"Vitamin D deficiency in postmenopausal women -biological correlates","volume":"9","author":"Capatina","year":"2014","journal-title":"Maedica (Buchar)."},{"key":"10.1016\/j.bone.2018.05.011_bb0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.18203\/2320-6012.ijrms20170140","article-title":"Levetiracetam monotherapy effect on serum calcium and serum vitamin D in patient of epilepsy","volume":"5","author":"Garg","year":"2017","journal-title":"Int. J. Res. Med. Sci."},{"key":"10.1016\/j.bone.2018.05.011_bb0180","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bone.2018.05.011_bb0185","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2165\/00023210-200519030-00003","article-title":"Effect of antiepileptic drugs on reproductive endocrine function in individuals with epilepsy","volume":"19","author":"Isojarvi","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.bone.2018.05.011_bb0190","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1359\/jbmr.080109","article-title":"RANKL inhibition with osteoprotegerin increases bone strength by improving cortical and trabecular bone architecture in ovariectomised rats","volume":"23","author":"Ominsky","year":"2008","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.bone.2018.05.011_bb0195","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1172\/JCI200317215","article-title":"Role of RANK ligand in mediating increased bone resorption in early postmenopausal women","volume":"111","author":"Eghbali-Fatourechi","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bone.2018.05.011_bb0200","doi-asserted-by":"crossref","first-page":"394","DOI":"10.5507\/bp.2014.006","article-title":"The effect of lacosamide on bone tissue in orchidectomised male albino Wistar rats","volume":"159","author":"Simko","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.bone.2018.05.011_bb0205","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bone.2013.08.016","article-title":"Effect of glucocorticoid treatment on Wnt signalling antagonists (sclerostin and DKK-1) and their relationship with bone turnover","volume":"57","author":"Gifre","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.bone.2018.05.011_bb0210","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.gene.2004.06.044","article-title":"Wnt signaling in osteoblasts and bone diseases","volume":"341","author":"Westendorf","year":"2004","journal-title":"Gene"},{"key":"10.1016\/j.bone.2018.05.011_bb0215","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00198-011-1675-1","article-title":"Long-term treatment with raloxifene, but not bisphosphonates, reduces circulating sclerostin levels in postmenopausal women","volume":"23","author":"Chung","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.05.011_bb0220","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s00198-010-1525-6","article-title":"Serum sclerostin levels positively correlate with lumbar spinal bone mineral density in postmenopausal women\u2014the six-month effect of risedronate and teriparatide","volume":"23","author":"Polyzos","year":"2012","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.bone.2018.05.011_bb0225","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jocd.2012.07.003","article-title":"Comparison of serum DKK-1 (Dickkopf-1) and bone mineral density in patients on bisphosphonate treatment vs no treatment","volume":"16","author":"Memon","year":"2013","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2018.05.011_bb0230","doi-asserted-by":"crossref","DOI":"10.1111\/bcpt.12996","article-title":"A cross-sectional study to assess the modulation of Wnt inhibitors following anti-epileptic drug therapy and their correlation with vitamin D and receptor activator of nuclear factor \u041a B ligand in Indian women with epilepsy","author":"Parveen","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.bone.2018.05.011_bb0235","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/art.23954","article-title":"Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization","volume":"58","author":"Yao","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.bone.2018.05.011_bb0240","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1210\/jc.2009-2283","article-title":"Serum sclerostin levels negatively correlate with parathyroid hormone levels and free estrogen index in postmenopausal women","volume":"95","author":"Mirza","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218301996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328218301996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T18:31:23Z","timestamp":1720290683000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328218301996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":48,"alternative-id":["S8756328218301996"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2018.05.011","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The anti-epileptic drugs valproate, carbamazepine and levetiracetam cause bone loss and modulate Wnt inhibitors in normal and ovariectomised rats","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2018.05.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}